Patent · US Active

Combinations and uses thereof

US9579378B2 · kind B2 · utility

3Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 24, 2013
Grant dateFeb 28, 2017
Priority date—
Expiry dateSep 24, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/545
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure describes a pharmaceutical combination of an anti-CD38 antibody and melphalan.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.